Insulin resistance predicts cognitive decline: An 11-year follow-up of a nationally representative adult population sample

Diabetes Care

Volumn 40, Issue 6, 2017, Pages 751-758

  Ekblad, Laura L ^a   Rinne, Juha O ^a,b   Puukka, Pauli ^c   Laine, Hanna ^a,b   Ahtiluoto, Satu ^d   Sulkava, Raimo ^d   Viitanen, Matti ^a,e   Jula, Antti ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; APOLIPOPROTEIN E4; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; COGNITION; COGNITIVE DECLINE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INFORMED CONSENT; INSULIN RESISTANCE; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; RISK FACTOR; AGED; BLOOD; COGNITIVE DEFECT; FINLAND; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; BLOOD GLUCOSE; COGNITION; COGNITIVE DYSFUNCTION; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; FOLLOW-UP STUDIES; GLYCATED HEMOGLOBIN A; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 85019761678     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-2001     Document Type: Article

References (39)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3:186-191
2. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999;53:1937-1942
3. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74
4. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012;42:484-491
5. Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2014;2:246-255
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607
7. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol 2012;32: 2060-2067
8. Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC.Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis. J Alzheimers Dis 2014;41:151-161
9. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Res Rev 2011;10:264-273
10. Kim B, Feldman EL. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med 2015;47:e149
11. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012;69:29-38
12. Claxton A, Baker LD,Wilkinson CW, et al. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J Alzheimers Dis 2013;35:789-797
13. Schuur M, Henneman P, van Swieten JC, et al. Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 2010;25:561-568
14. Benedict C, Brooks SJ, Kullberg J, et al. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 2012;35:488-494
15. Ekblad LL, Rinne JO, Puukka PJ, et al. Insulin resistance is associated with poorer verbal fluency performance in women. Diabetologia 2015;58:2545-2553
16. Abbatecola AM, Paolisso G, Lamponi M, et al. Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc 2004;52: 1713-1718
17. Geroldi C, Frisoni GB, Paolisso G, et al. Insulin resistance in cognitive impairment: the InCHIANTI study.ArchNeurol 2005;62:1067-1072
18. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998;31:780-786
19. Young SE, Mainous AG 3rd, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 2006;29: 2688-2693
20. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242
21. Aromaa A, Koskinen S. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey [Internet], 2004. Helsinki, Finland, National Public Health Institute. Available from http://urn.fi/URN:NBN:fife201204193452. Accessed 1 June 2016
22. Lundqvist A, Mäki-Opas T, Eds. Health 2011 survey-methods [Internet], 2016. Tampere, Finland, Finnish National Institute for Health and Welfare. Available from http://urn.fi/URN:ISBN: 978-952-302-669-8. Accessed 1 September 2016
23. Heistaro S, Ed. Methodology report. Health 2000 survey [Internet], 2008. Helsinki, Finland, National Public Health Institute. Available from http://urn.fi/URN:NBN:fi-fe201204193320. Accessed 1 June 2016
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
25. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165
26. Hänninen T, Pulliainen V, Salo J, et al. ja Suomen muistitutkimusyksiköiden asiantuntijaryhmä. Kognitiiviset testit muistihäiriöiden ja alkavan dementian varhaisdiagnostiikassa: CERADteht äväsarja. Suom Laakaril 1999;54:1967-1975
27. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX, Psychological Corporation, 1996
28. Jänis MT, Siggins S, Tahvanainen E, et al. Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample. J Lipid Res 2004;45:2303-2309
29. McEvoy LK, Laughlin GA, Barrett-Connor E, et al. Metabolic syndrome and 16-year cognitive decline in community-dwelling older adults. Ann Epidemiol 2012;22:310-317
30. Gourovitch ML, Kirkby BS, Goldberg TE, et al. A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology 2000;14:353-360
31. Shao Z, Janse E, Visser K,Meyer AS.What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Front Psychol 2014;5:772
32. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2011;68:51-57
33. Willette AA, Bendlin BB, Starks EJ, et al. Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. JAMA Neurol 2015;72:1013-1020
34. Langbaum JB, Chen K, Lee W, et al.; Alzheimer's Disease Neuroimaging Initiative. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 2009; 45:1107-1116
35. Willette AA, Xu G, Johnson SC, et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 2013;36:443-449
36. Segura B, Jurado MA, Freixenet N, Falcón C, Junqué C, Arboix A. Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study. Neurology 2009;73:438-444
37. Makino T, Umegaki H, Suzuki Y, et al. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment. Geriatr Gerontol Int 2014;14:819-826
38. Twamley EW, Ropacki SA, Bondi MW. Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2006;12:707-735
39. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351-357